HNN3.0
Register
Register
Register

Project cooperationUpdated on 26 October 2026

R&D for Rare Disease Precision Medicine

CEO at Genorare

Zurich, Switzerland

About

We are seeking project partners to collaborate on the development, validation, and deployment of privacy-preserving AI solutions for rare disease diagnosis and intelligent clinical trial matching.

We welcome collaborations with hospitals, universities, research institutes, patient organizations, pharmaceutical and biotech companies, and digital health innovators. Potential cooperation areas include:

  • Clinical validation of AI models for rare disease diagnosis

  • Federated learning and privacy-preserving health data analysis

  • Integration with hospital EHR and genomic systems

  • AI-powered patient identification and clinical trial recruitment

  • Joint R&D, grant applications, and European research projects

  • Real-world evidence generation and multi-center clinical studies

Our goal is to accelerate rare disease diagnosis and improve patient access to precision medicine while ensuring the highest standards of data privacy and regulatory compliance.

Partner types sought: Hospitals, research organizations, universities, patient advocacy groups, pharmaceutical and biotech companies, CROs, and digital health technology providers.

Topic

  • Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
  • Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
  • Destination 5: HORIZON-HLTH-2027-03-TOOL-08: Towards the next generation of frontier Artificial Intelligence models for healthcare

Organisation

Genorare

Start-up

Amsterdam, Netherlands

Similar opportunities